SERAGON PHARMACEUTICALS Trademark

Trademark Overview

On Wednesday, September 16, 2020, a trademark application was filed for SERAGON PHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the SERAGON PHARMACEUTICALS trademark a serial number of 90185092. The federal status of this trademark filing is REGISTERED as of Tuesday, April 20, 2021. This trademark is owned by Seragon Pharmaceuticals Inc.. The SERAGON PHARMACEUTICALS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and development
seragon pharmaceuticals

General Information

Serial Number90185092
Word MarkSERAGON PHARMACEUTICALS
Filing DateWednesday, September 16, 2020
Status700 - REGISTERED
Status DateTuesday, April 20, 2021
Registration Number6328688
Registration DateTuesday, April 20, 2021
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 2, 2021

Trademark Statements

NOT AVAILABLE"PHARMACEUTICALS"
Goods and ServicesPharmaceutical research and development

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, October 26, 2020
Primary Code042
First Use Anywhere DateWednesday, April 1, 2020
First Use In Commerce DateWednesday, April 1, 2020

Trademark Owner History

Party NameSeragon Pharmaceuticals Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressIrvine, CA 92618
Party NameSeragon Pharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIrvine, CA 92618
Party NameSeragon Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIrvine, CA 92618

Trademark Events

Event DateEvent Description
Saturday, September 19, 2020NEW APPLICATION ENTERED
Friday, October 23, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, October 23, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, October 23, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, October 26, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, December 23, 2020ASSIGNED TO EXAMINER
Wednesday, December 23, 2020EXAMINERS AMENDMENT E-MAILED
Wednesday, December 23, 2020EXAMINERS AMENDMENT -WRITTEN
Wednesday, December 23, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, December 23, 2020EXAMINER'S AMENDMENT ENTERED
Tuesday, April 20, 2021REGISTERED-PRINCIPAL REGISTER
Monday, October 17, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, December 23, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 13, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 2, 2021PUBLISHED FOR OPPOSITION
Tuesday, February 2, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, October 17, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, July 9, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, July 9, 2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, July 9, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, July 9, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, October 17, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED

Related Keywords

pharmaceuticals seragon development research pharmaceutical